The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUtilico Emerging Markets Regulatory News (UEM)

Utilico Insights; International Container Terminal Services

Utilico Insights; International Container Terminal Services

Share Price Information for Utilico Emerging Markets (UEM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 233.00
Bid: 228.00
Ask: 233.00
Change: 0.00 (0.00%)
Spread: 5.00 (2.193%)
Open: 233.00
High: 0.00
Low: 0.00
Prev. Close: 233.00
UEM Live PriceLast checked at -
Utilico Emerging Markets Trust is an Investment Trust

UEM is a unique UK listed fund focused on global infrastructure megatrends in emerging markets with an investment objective to provide long-term total return through a flexible investment policy.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Monthly Factsheet

8 Mar 2024 12:43

RNS Number : 1978G
Utilico Emerging Markets Trust PLC
08 March 2024
 

8 March 2024

UTILICO EMERGING MARKETS TRUST PLC

(LEI Number: 2138005TJMCWR2394O39)

 

Publication of monthly factsheet

 

The latest monthly factsheet for Utilico Emerging Markets Trust plc ("UEM" or the "Company") will shortly be available through the Company's website at:

https://www.uemtrust.co.uk/investor-relations/factsheet-archive

 

Monthly commentary

 

PERFORMANCE

UEM's NAV total return increased by 0.6% in February, underperforming the MSCI Emerging Markets total return Index ("MSCI") which was up by 5.6% in Sterling terms in the month. Since 31 March 2023, UEM's NAV total return has increased by 9.7%, significantly better than the MSCI which was up by 3.3% in Sterling terms over the same period.

 

Global markets were fairly strong in February despite the more hawkish message from the US Federal Reserve that interest rates are likely to remain higher for longer as economic data from the US continued to be resilient. The US composite Purchasing Managers' Index (PMI) remained in expansionary territory and January's US nonfarm payroll data was ahead of expectations. The US market was also supported by the positive 4Q 2023 earnings reported (five of the 'Magnificent Seven' released results broadly meeting or exceeding expectations), helping to drive the S&P Index up by 5.2% over period and reaching a new all-time high in February. The Eurostoxx Index followed suit up 4.9% over the period whilst the UK's FTSE 100 Index was flat, despite data pointing to an improving outlook, as GDP fell in the final quarter of 2023 by 0.3% dragging the UK into technical recession.

 

In emerging markets, the Chinese Shanghai Composite Index ended the month where it started the year, up by 8.1% for February. The market was boosted by more positive activity data over the Lunar New Year period as well as more supportive economic and financial measures being announced by the government such as cutting the five-year loan prime rates (benchmark for mortgage rates) by 25bps and banning short selling. The Hang Seng Index was also up by 6.6%. Elsewhere in Asia the markets were also positive with the Vietnamese Ho Chi Minh Index up by 7.6% driven by the improvement in consumer confidence and the Philippines market up by 4.5%. The Indonesian market was up by a modest 1.5%, despite Prabowo-Gibran winning the presidential election by a one-round landslide victory, becoming the country's eighth president. In India, the SENSEX Index was up by 1.2%.

 

In Latam, the outperformer for the month was Chile, with the IPSA Index up by 7.7%. January's CPI data revealed inflation was significantly lower than expected at 3.2% and this, along with the weak economic activity reduced inflationary pressures, enabling the Chilean central bank to reduce interest rates more aggressively. Elsewhere Brazil remained subdued, with the Bovespa Index up by 1.0%, slowing down after its strong rally at the end of 2023. The Mexican market was down by 3.4% hampered partly by January's inflationary figures which were reported higher than expected resulting in Banxico (Mexico's central bank) keeping interest rates at 11.25%. Further, Mexico's President Andrés Manuel López Obrador recently proposed reforms created additional noise in the market.

 

In the currency markets, Sterling weakened against most currencies, down 0.7% against the US Dollar, down 0.8% against the Indian Rupee and relatively flat against the Brazilian Real down by 0.1%.

 

PORTFOLIO

There were two changes to the top thirty holdings, with TAV Havalimanlari Holding ("TAV") becoming a new entrant and Shanghai International Airport ("SIA") re-entering, replacing Telelink and Sonatel that have dropped out on relative performance. TAV is a Turkish listed airport operator that currently operates 15 airports and terminals across eight countries, including Turkey and Kazakhstan, handling in total 95.5m passengers in 2023. Both new top thirty entrants are capitalising on the social infra megatrend that UEM is currently witnessing across the emerging markets of the growth of the middle class that is demanding better quality services and infrastructure and has a higher propensity to travel.

 

Performance across the portfolio in February was mixed. The strong performers for the month were TAV, up by 26.2%, International Container Terminals up 18.8% and FPT Corporation up by 13.9%. Both TAV and FPT witnessed strong performance on the back of solid FY23 results with TAV reporting

passenger numbers up by 21.8% and EBITDA up by 19.4% for 2023 whilst FPT reported 20.0% growth in its top line and a 22.0% rise in its bottom line, ahead of market expectations. Power Grid was also up by 9.1% as the Indian company also reported positive quarterly results which saw improving momentum with several new project wins.

 

The weaker performers for the month were Kinx Inc, down by 13.5%, reflective of some investors taking profit given its strong performance into the end of January, whilst Holding Bursatil Regional (the new holding company that has originated from the merger of the Colombian, Chilean and Peruvian exchanges) was down by 5.9%.

 

In light of continued declines in listed EV charging share prices and headwinds for fund raisings by early stage companies, the valuation of UEM's investment in Petalite was also reduced in February by approximately 50%. Unlisted investments represent in aggregate 4.5% of UEM's portfolio as at 29 February 2024.

 

Portfolio purchases amounted to £7.8m and realisations totalled £17.6m.

 

DEBT

UEM's debt increased marginally over February from £25.9m to £26.0m, drawn as GBP 3.7m and EUR 26.0m.

OTHER

UEM's share price ended February at 223.00p, decreasing 2.4% over the month. The discount to NAV widened from 14.5% to 17.0%. UEM bought back 1.9m shares at an average price of 226.94p in the month. This takes the total shares bought back in the eleven months to 29 February 2024 to 10.7m, equivalent to 5.3% of the share capital as at 31 March 2023. 

 

The third quarterly interim dividend of 2.15p per ordinary share in respect of the year ending 31 March 2024, was declared in February, and will be paid on 28 March 2024 to shareholders on the register on 8 March 2024.

 

 

Name of contact and telephone number for enquiries:

ICM Investment Management Limited +44(0)1372 271486

Charles Jillings / Alastair Moreton

 

Montfort Communications

Gay Collins, Pippa Bailey +44(0)20 3770 7913

utilico@montfort.london

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCQKFBQBBKDBNK
Date   Source Headline
25th Aug 202311:15 amRNSNet Asset Value(s)
24th Aug 20235:11 pmRNSTransaction in Own Shares & Total Voting Rights
24th Aug 202312:23 pmRNSNet Asset Value(s)
23rd Aug 202311:39 amRNSNet Asset Value(s)
22nd Aug 202311:02 amRNSNet Asset Value(s)
21st Aug 202311:10 amRNSNet Asset Value(s)
18th Aug 20235:38 pmRNSTransaction in Own Shares & Total Voting Rights
18th Aug 202311:13 amRNSDividend Declaration Q1 2023-24
18th Aug 202311:12 amRNSNet Asset Value(s)
17th Aug 20235:25 pmRNSTransaction in Own Shares & total Voting Rights
17th Aug 202311:13 amRNSNet Asset Value(s)
16th Aug 20235:04 pmRNSTransaction in Own Shares & Total Voting Rights
16th Aug 202311:18 amRNSNet Asset Value(s)
15th Aug 20235:19 pmRNSTransaction in Own Shares & Total Voting Rights
15th Aug 202312:57 pmRNSPublication of monthly factsheet
15th Aug 202311:42 amRNSNet Asset Value(s)
14th Aug 20234:58 pmRNSTransaction in Own Shares & Total Voting Rights
14th Aug 202311:34 amRNSNet Asset Value(s)
11th Aug 20234:53 pmRNSTransaction in Own Shares & Total Voting Rights
11th Aug 202311:33 amRNSNet Asset Value(s)
10th Aug 20235:08 pmRNSTransaction in Own Shares & Total Voting Rights
10th Aug 202311:16 amRNSNet Asset Value(s)
9th Aug 202311:30 amRNSNet Asset Value(s)
8th Aug 202311:56 amRNSNet Asset Value(s)
7th Aug 202311:09 amRNSNet Asset Value(s)
4th Aug 202311:52 amRNSNet Asset Value(s)
3rd Aug 202311:34 amRNSNet Asset Value(s)
2nd Aug 202312:47 pmRNSNet Asset Value(s)
1st Aug 202312:04 pmRNSNet Asset Value(s)
31st Jul 20235:13 pmRNSTransaction in Own Shares & Total Voting Rights
31st Jul 202312:53 pmRNSNet Asset Value(s)
28th Jul 202311:50 amRNSNet Asset Value(s)
27th Jul 20235:09 pmRNSTransaction in Own Shares & Total Voting Rights
27th Jul 202311:22 amRNSNet Asset Value(s)
26th Jul 202311:23 amRNSNet Asset Value(s)
25th Jul 202311:01 amRNSNet Asset Value(s)
24th Jul 20235:07 pmRNSTransaction in Own Shares & Total Voting Rights
24th Jul 202311:50 amRNSNet Asset Value(s)
21st Jul 20234:30 pmRNSTransaction in Own Shares & Total Voting Rights
21st Jul 202311:58 amRNSNet Asset Value(s)
20th Jul 202311:38 amRNSNet Asset Value(s)
19th Jul 202311:49 amRNSNet Asset Value(s)
18th Jul 20235:06 pmRNSTransaction in Own Shares & Total Voting Rights
18th Jul 202311:09 amRNSNet Asset Value(s)
17th Jul 202311:31 amRNSNet Asset Value(s)
14th Jul 20234:46 pmRNSTransaction in Own Shares & Total Voting Rights
14th Jul 202311:28 amRNSNet Asset Value(s)
13th Jul 202312:12 pmRNSNet Asset Value(s)
12th Jul 20233:31 pmRNSPublication of monthly factsheet
12th Jul 202312:26 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.